Xu SX - Search Results

1

Case report: Clinicopathological characteristic of two cases of primary endometrial squamous cell carcinoma and review of the literature.

Zhang HB, Lin LH, Lin QP, Lin YQ, Luo D, Xu SX. Zhang HB, et al. Among authors: xu sx. Front Oncol. 2024 Aug 26;14:1415816. doi: 10.3389/fonc.2024.1415816. eCollection 2024. Front Oncol. 2024. PMID: 39252944 Free PMC article.

2

Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.

Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, Sun P. Lei H, et al. J Inflamm Res. 2021 Dec 21;14:7131-7142. doi: 10.2147/JIR.S345790. eCollection 2021. J Inflamm Res. 2021. PMID: 34992410 Free PMC article.

3

ERRα Up-Regulates Invadopodia Formation by Targeting HMGCS1 to Promote Endometrial Cancer Invasion and Metastasis.

Tang S, Ma J, Su P, Lei H, Tong Y, Cai L, Xu S, Mao X, Sun P. Tang S, et al. Int J Mol Sci. 2023 Feb 16;24(4):4010. doi: 10.3390/ijms24044010. Int J Mol Sci. 2023. PMID: 36835419 Free PMC article.

4

Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEP.

Huang G, Gao H, Chen Y, Lin W, Shen J, Xu S, Liu D, Wu Z, Lin X, Jiang T, Dong B, Sun P. Huang G, et al. J Inflamm Res. 2023 May 1;16:1923-1936. doi: 10.2147/JIR.S406082. eCollection 2023. J Inflamm Res. 2023. PMID: 37152868 Free PMC article.

5

HPV positivity status in males is related to the acquisition of HPV infection in females in heterosexual couples.

Huang Y, Kang Y, Li Y, Cai L, Wu Q, Liu D, Mao X, Huang L, Osafo KS, Zhang Y, Xu S, Dong B, Sun P. Huang Y, et al. Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):469-480. doi: 10.1007/s10096-023-04722-6. Epub 2024 Jan 4. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38172404 Free PMC article.

6

Prognostic Prediction for Recurrent/Residual CIN in HSIL Patients After Conization: An Updated Retrospective Study Based on Ambulatory Surgery.

Huang G, Lin W, Gao H, Ren Y, Shen J, Xu S, Liu D, Cai Y, Lin C, Lin X, Jiang T, Dong B, Sun P. Huang G, et al. J Inflamm Res. 2024 Nov 19;17:9087-9102. doi: 10.2147/JIR.S494622. eCollection 2024. J Inflamm Res. 2024. PMID: 39583852 Free PMC article.

7

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China.

Ruan G, Song Y, Dong B, Mao X, Lin F, Kang Y, Xu S, Chen X, Wu Q, Sun P. Ruan G, et al. Cancer Manag Res. 2018 Sep 4;10:3227-3235. doi: 10.2147/CMAR.S169822. eCollection 2018. Cancer Manag Res. 2018. PMID: 30233239 Free PMC article.

8

Clinical validation of the Cervista^® high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study.

Mao X, Ruan G, Dong B, Chen L, Xu S, Lin F, Sun P. Mao X, et al. Ther Clin Risk Manag. 2018 Nov 16;14:2243-2253. doi: 10.2147/TCRM.S179334. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30532547 Free PMC article.

9

Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer.

Ma J, Lin J, Lin X, Ren Y, Liu D, Tang S, Huang L, Xu S, Mao X, Sun P. Ma J, et al. J Inflamm Res. 2024 Apr 2;17:2039-2050. doi: 10.2147/JIR.S453337. eCollection 2024. J Inflamm Res. 2024. PMID: 38585471 Free PMC article.

10

Multi-omics profiling reveal cells with novel oncogenic cluster, TRAP1^low/CAMSAP3^low, emerge more aggressive behavior and poor-prognosis in early-stage endometrial cancer.

Mao X, Tang X, Ye J, Xu S, Wang Y, Liu X, Wu Q, Lin X, Zhang M, Liu J, Yang J, Sun P. Mao X, et al. Mol Cancer. 2024 Jun 17;23(1):127. doi: 10.1186/s12943-024-02039-2. Mol Cancer. 2024. PMID: 38880903 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters